Dimethyl fumarate: a Janus-faced substance?

PML in a Patient Treated with Dimethyl Fumarate from a Compounding Pharmacy

(2013) Bob W. van Oosten et al.   NEW ENGLAND JOURNAL OF MEDICINE

Manufacturer's Response to Case Reports of PML

(2013) Marianne T. Sweetser et al.   NEW ENGLAND JOURNAL OF MEDICINE

Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis

(2012) Robert J. Fox et al.   NEW ENGLAND JOURNAL OF MEDICINE

Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis

(2012) Ralf Gold et al.   NEW ENGLAND JOURNAL OF MEDICINE

Roles of Reactive Oxygen Species and Antioxidants in Ovarian Toxicity1

(2011) Patrick J. Devine et al.   BIOLOGY OF REPRODUCTION

Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway

(2011) Ralf A. Linker et al.   BRAIN

High Basal Nuclear Levels of Nrf2 in Acute Myeloid Leukemia Reduces Sensitivity to Proteasome Inhibitors

(2011) S. A. Rushworth et al.   CANCER RESEARCH

Antioxidant protection: A promising therapeutic intervention in neurodegenerative disease

(2011) Nilanjan Ghosh et al.   FREE RADICAL RESEARCH

Dimethyl fumarate contact dermatitis of the foot: an increasingly widespread disease

(2011) Angelo Massimiliano D’Erme et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

Pharmacokinetics of anti-psoriatic fumaric acid esters in psoriasis patients

(2010) Martin Rostami-Yazdi et al.   ARCHIVES OF DERMATOLOGICAL RESEARCH

Glatiramer Acetate

(2010) Natalie J. Carter et al.   DRUGS

Nrf2 and DJ1 are consistently upregulated in inflammatory multiple sclerosis lesions

(2010) Jack van Horssen et al.   FREE RADICAL BIOLOGY AND MEDICINE

BG-12 reduces evolution of new enhancing lesions to T1-hypointense lesions in patients with multiple sclerosis

(2010) D. G. MacManus et al.   JOURNAL OF NEUROLOGY

Enhanced number and activity of mitochondria in multiple sclerosis lesions

(2009) Maarten E Witte et al.   JOURNAL OF PATHOLOGY

An outbreak of furniture related dermatitis (‘sofa dermatitis’) in Finland and the UK: history and clinical cases

(2009) P Susitaival et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Clinical trials of multiple sclerosis therapies: improvements to demonstrate long-term patient benefit

(2009) WM Carroll   Multiple Sclerosis Journal

Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2

(2008) X.-J. Wang et al.   CARCINOGENESIS

Detection of Metabolites of Fumaric Acid Esters in Human Urine: Implications for Their Mode of Action

(2008) Martin Rostami-Yazdi et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

(2008) Ludwig Kappos et al.   LANCET

Multiple sclerosis

(2008) Alastair Compston et al.   LANCET

Hormetic Dietary Phytochemicals

(2008) Tae Gen Son et al.   NEUROMOLECULAR MEDICINE

Dual roles of Nrf2 in cancer

(2008) A LAU et al.   PHARMACOLOGICAL RESEARCH